IL2 and cancer: Under normal physiological conditions, IL-2 binds to the high-affinity IL-2 receptor on T cells to promote their proliferation and differentiation, particularly into CD8+ cytotoxic T cells and regulatory T cells, which help carry out the immune response and target cancer cells [19].